Reality of surgical treatment of atrial fibrillation in the
Czech Republic - Data from the National Register of Cardiac
Surgery (2010-2015)

J 2017

Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015)

BUDERA, P., V. KURFIRST, S. CERNY, P. NEMEC, J. PIRK et. al.

Základní údaje

Originální název

Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015)

Autoři

BUDERA, P. (203 Česká republika), V. KURFIRST (203 Česká republika), S. CERNY (203 Česká republika), P. NEMEC (203 Česká republika), J. PIRK (203 Česká republika), J. LINDNER (203 Česká republika), V. ROHN (203 Česká republika), A. MOKRACEK (203 Česká republika), T. HAJEK (203 Česká republika), M. POJAR (203 Česká republika), R. BRAT (203 Česká republika), P. SANTAVY (203 Česká republika), P. BRANNY (203 Česká republika), Klára BENEŠOVÁ (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, garant, domácí) a Z. STRAKA (203 Česká republika)

Vydání

Cor et Vasa, AMSTERDAM, ELSEVIER SCIENCE BV, 2017, 0010-8650

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/17:00098153

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.crvasa.2017.05.010

UT WoS

000410033600005

Klíčová slova anglicky

Atrial fibrillation; Surgical ablation; Register; Concomitant; Miniinvasive; Hybrid ablation

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 22. 3. 2018 16:39, Soňa Böhmová

Anotace

V originále

Introduction: Surgical ablation is an established treatment for atrial fibrillation (AF) in certain patients indicated for cardiac surgery. However, several strategies and approaches exist at different centers and no recent reports exist about current trends in AF treatment in the Czech Republic. We examined the national trends of concomitant and stand-alone surgical ablation of AF. Methods: Data from the National Register of Cardiac Surgery and from a special questionnaire, created especially for this analysis, were used for evaluation of trends in the rate of concomitant surgical ablations in AF patients, rates of different concomitant procedures, and to analysis those factors that surgeons routinely used to reject AF treatment during cardiac surgery. Data about stand-alone AF surgery were also gathered and analyzed. The study period lasted from 2010-2015. Results: Overall, 54% of cardiac surgery patients with history of AF received a concomitant surgical ablation procedure; this percentage declined slightly over the study period from 59% in 2010 to 51% in 2015. Concomitant ablation was most often performed on mitral valve patients (71%) and least often during isolated coronary revascularization (40%). In a multivariant analysis, age, history of myocardial infarction, history of cardiac surgery, renal failure, severe systolic dysfunction of the left ventricle (i.e., ejection fraction <= 30%), and preoperative hemodynamic instability were identified as strongest independent factors that causes surgeons to reject AF treatment during an non-AF cardiac surgery. Stand-alone AF surgery was performed in 9 (75%) Czech centers during the study period with a total of 132 procedures; this method has been abandoned by most centers, while several have switched to a hybrid ablation (HA) strategy. Hybrid ablation programs were ongoing in 5 centers in 2016, the overall number of procedures through the end of 2015 was 144. Conclusions: The prevalence of surgical AF treatment in cardiac surgery patients has been slightly decreasing, and in almost half of the patients AF was left untreated. Stand-alone AF surgery has been nearly abandoned, while hybrid treatment has slowly expanded in Czech centers. (C) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. zo.o. All rights reserved.

Citovat

BUDERA, P., V. KURFIRST, S. CERNY, P. NEMEC, J. PIRK, J. LINDNER, V. ROHN, A. MOKRACEK, T. HAJEK, M. POJAR, R. BRAT, P. SANTAVY, P. BRANNY, Klára BENEŠOVÁ, Jiří JARKOVSKÝ a Z. STRAKA. Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015). Cor et Vasa. AMSTERDAM: ELSEVIER SCIENCE BV, 2017, roč. 59, č. 4, s. "E305"-"E311", 7 s. ISSN 0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2017.05.010.

@article{1394345,
   author = {Budera, P. and Kurfirst, V. and Cerny, S. and Nemec, P. and Pirk, J. and Lindner, J. and Rohn, V. and Mokracek, A. and Hajek, T. and Pojar, M. and Brat, R. and Santavy, P. and Branny, P. and Benešová, Klára and Jarkovský, Jiří and Straka, Z.},
   article_location = {AMSTERDAM},
   article_number = {4},
   doi = {http://dx.doi.org/10.1016/j.crvasa.2017.05.010},
   keywords = {Atrial fibrillation; Surgical ablation; Register; Concomitant; Miniinvasive; Hybrid ablation},
   language = {eng},
   issn = {0010-8650},
   journal = {Cor et Vasa},
   title = {Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015)},
   volume = {59},
   year = {2017}
}

TY  - JOUR
ID  - 1394345
AU  - Budera, P. - Kurfirst, V. - Cerny, S. - Nemec, P. - Pirk, J. - Lindner, J. - Rohn, V. - Mokracek, A. - Hajek, T. - Pojar, M. - Brat, R. - Santavy, P. - Branny, P. - Benešová, Klára - Jarkovský, Jiří - Straka, Z.
PY  - 2017
TI  - Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015)
JF  - Cor et Vasa
VL  - 59
IS  - 4
SP  - "E305"-"E311"
EP  - "E305"-"E311"
PB  - ELSEVIER SCIENCE BV
SN  - 00108650
KW  - Atrial fibrillation
KW  - Surgical ablation
KW  - Register
KW  - Concomitant
KW  - Miniinvasive
KW  - Hybrid ablation
N2  - Introduction: Surgical ablation is an established treatment for atrial fibrillation (AF) in certain patients indicated for cardiac surgery. However, several strategies and approaches exist at different centers and no recent reports exist about current trends in AF treatment in the Czech Republic. We examined the national trends of concomitant and stand-alone surgical ablation of AF. Methods: Data from the National Register of Cardiac Surgery and from a special questionnaire, created especially for this analysis, were used for evaluation of trends in the rate of concomitant surgical ablations in AF patients, rates of different concomitant procedures, and to analysis those factors that surgeons routinely used to reject AF treatment during cardiac surgery. Data about stand-alone AF surgery were also gathered and analyzed. The study period lasted from 2010-2015. Results: Overall, 54% of cardiac surgery patients with history of AF received a concomitant surgical ablation procedure; this percentage declined slightly over the study period from 59% in 2010 to 51% in 2015. Concomitant ablation was most often performed on mitral valve patients (71%) and least often during isolated coronary revascularization (40%). In a multivariant analysis, age, history of myocardial infarction, history of cardiac surgery, renal failure, severe systolic dysfunction of the left ventricle (i.e., ejection fraction <= 30%), and preoperative hemodynamic instability were identified as strongest independent factors that causes surgeons to reject AF treatment during an non-AF cardiac surgery. Stand-alone AF surgery was performed in 9 (75%) Czech centers during the study period with a total of 132 procedures; this method has been abandoned by most centers, while several have switched to a hybrid ablation (HA) strategy. Hybrid ablation programs were ongoing in 5 centers in 2016, the overall number of procedures through the end of 2015 was 144. Conclusions: The prevalence of surgical AF treatment in cardiac surgery patients has been slightly decreasing, and in almost half of the patients AF was left untreated. Stand-alone AF surgery has been nearly abandoned, while hybrid treatment has slowly expanded in Czech centers. (C) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. zo.o. All rights reserved.
ER  -

BUDERA, P., V. KURFIRST, S. CERNY, P. NEMEC, J. PIRK, J. LINDNER, V. ROHN, A. MOKRACEK, T. HAJEK, M. POJAR, R. BRAT, P. SANTAVY, P. BRANNY, Klára BENEŠOVÁ, Jiří JARKOVSKÝ a Z. STRAKA. Reality of surgical treatment of atrial fibrillation in the Czech Republic - Data from the National Register of Cardiac Surgery (2010-2015). \textit{Cor et Vasa}. AMSTERDAM: ELSEVIER SCIENCE BV, 2017, roč.~59, č.~4, s.~''E305''-''E311'', 7 s. ISSN~0010-8650. Dostupné z: https://dx.doi.org/10.1016/j.crvasa.2017.05.010.

Podrobný výpis o publikaci